UK Is First Country to Approve Moderna Omicron-Targeted Vaccine
Updated vaccine targeted to the Omicron variant is expected to have “important role” in protecting people from COVID-19 this winter
Updated vaccine targeted to the Omicron variant is expected to have “important role” in protecting people from COVID-19 this winter
Discovery of poliovirus in sewage samples suggests there is already community transmission of the virus.
Under the EUA, Jynneos can be administered either intradermally for individuals aged ≥18 years or subcutaneously for individuals aged <18 years.
An individual is considered fully vaccinated about 2 weeks after the second dose of Jynneos and 4 weeks after receiving ACAM2000.
Adults at risk of hepatitis A and hepatitis B have multi-dose vaccinations available, but complete and timely vaccination adherence rates are low. What can be done to encourage more vaccine adherence?
The Novavax COVID-19 Vaccine, Adjuvanted is administered intramuscularly as a 2-dose primary series (0.5mL each), separated by 3 weeks.
The approval was based on data from a phase 3 trial which included 2260 adolescents 12 to 15 years of age enrolled in the United States.
For children, Vaxneuvance is administered as a 4-dose series at 2, 4, 6 and 12 through 15 months of age (and at least 2 months after the 3rd dose).
Children with physical disabilities, neurologic and neurodevelopmental disorders, and autism are at higher risk for vaccine-preventable illnesses.
No increase in vaccine uptake seen for individuals receiving text message vs phone calls or for behaviorally informed message content.